Benign recurrent lymphocytic meningitis (Mollaret's meningitis) in Denmark: a nationwide cohort study
Open Access
- 5 October 2023
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 31 (1)
Abstract
Background and purpose: Data on clinical features and outcomes of benign recurrent lymphocytic meningitis (BRLM) are limited.Methods: This was a nationwide population‐based cohort study of all adults hospitalized for BRLM associated with herpes simplex virus type 2 (HSV‐2) at the departments of infectious diseases in Denmark from 2015 to 2020. Patients with single‐episode HSV‐2 meningitis were included for comparison.Results: Forty‐seven patients with BRLM (mean annual incidence 1.2/1,000,000 adults) and 118 with single‐episode HSV‐2 meningitis were included. The progression risk from HSV‐2 meningitis to BRLM was 22% (95% confidence interval [CI] 15%–30%). The proportion of patients with the triad of headache, neck stiffness and photophobia/hyperacusis was similar between BRLM and single‐episode HSV‐2 meningitis (16/43 [37%] vs. 46/103 [45%]; p = 0.41), whilst the median cerebrospinal fluid leukocyte count was lower in BRLM (221 cells vs. 398 cells; p = 0.02). Unfavourable functional outcomes (Glasgow Outcome Scale score of 1–4) were less frequent in BRLM at all post‐discharge follow‐up visits. During the study period, 10 (21%) patients with BRLM were hospitalized for an additional recurrence (annual rate 6%, 95% CI 3%–12%). The hazard ratio for an additional recurrence was 3.93 (95% CI 1.02–15.3) for patients with three or more previous episodes of meningitis.Conclusions: Clinical features of BRLM were similar to those of single‐episode HSV‐2 meningitis, whilst post‐discharge outcomes were more favourable. Patients with three or more previous episodes of meningitis had higher risk of an additional recurrence.Keywords
Funding Information
- Helen Rudes Fond (60988)
- Helsefonden (21‐B‐0437)
- Minister Erna Hamiltons Legat for Videnskab og Kunst (24‐2022)
- Nordsjællands Hospital
This publication has 20 references indexed in Scilit:
- Long-term Valacyclovir Suppressive Treatment After Herpes Simplex Virus Type 2 Meningitis: A Double-Blind, Randomized Controlled TrialClinical Infectious Diseases, 2012
- The Danish National Patient RegisterScandinavian Journal of Public Health, 2011
- Recurrent Lymphocytic Meningitis Positive for Herpes Simplex Virus Type 2Emerging Infectious Diseases, 2009
- Increased Detection Rate in Diagnosis of Herpes Simplex Virus Type 2 Meningitis by Real-Time PCR Using Cerebrospinal Fluid SamplesJournal of Clinical Microbiology, 2007
- Mollaret's meningitis: Cytopathologic analysis of fourteen casesDiagnostic Cytopathology, 2003
- Herpes simplex virus type 2 DNA detected in cerebrospinal fluid of 9 patients with Mollaret's meningitisActa Neurologica Scandinavica, 1998
- Recurrence Rates in Genital Herpes after Symptomatic First-Episode InfectionAnnals of Internal Medicine, 1994
- Herpes Simplex Virus Infection as a Cause of Benign Recurrent Lymphocytic MeningitisAnnals of Internal Medicine, 1994
- Primary and Recurrent Herpes Simplex Virus Type 2-Induced MeningitisThe Journal of Infectious Diseases, 1990
- ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical ScaleThe Lancet, 1975